← Back to Search

Behavioral Intervention

Stress Management and Relaxation Training/Expressive Supportive Therapy (SMART/EST) for Depression (eSMARTEST Trial)

N/A

Waitlist Available

Research Sponsored by Albert Einstein College of Medicine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and week 9

Awards & highlights

eSMARTEST Trial Summary

This trial will test a teletherapy intervention for depression in older HIV-positive women. The intervention has been successful in previous trials with HIV-positive women and will be adapted to be done over video call with peer support.

Eligible Conditions

Depression
HIV (Human Immunodeficiency Virus)

eSMARTEST Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and week 9

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and week 9

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and week 9 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Decrease in score from Baseline in Anxiety on 21-item Beck Anxiety Inventory (BAI) at Week 9

Decrease in score from Baseline in Depression on 21-item Beck Depression Inventory (BDI) at Week 9

eSMARTEST Trial Design

1Treatment groups

Experimental Treatment

Group I: GroupExperimental Treatment1 Intervention

Intervention consists of a psychotherapy trial using cognitive-behavioral stress management/expressive supportive therapy to target depression among HIV-positive older women. Dosage: 8 sessions. Frequency: weekly. Duration: 8 weeks.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Stress Management and Relaxation Training/Expressive Supportive Therapy (SMART/EST)

2023

N/A

~10

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Albert Einstein College of MedicineLead Sponsor

286 Previous Clinical Trials

11,856,971 Total Patients Enrolled

7 Trials studying Depression

1,698 Patients Enrolled for Depression

Harris Goldstein, MDStudy DirectorEinstein-Rockefeller-City University of New York Center for AIDS Research

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can I register to take part in this research endeavor?

"This study is seeking 10 elderly patients with depression and HIV who have had symptoms for the last year. Other requirements include having access to teletherapy, as well as being able to communicate in English fluently."

Answered by AI

Is there a current call for participants in this medical experiment?

"Yes, the trial is still ongoing. The information on clinicaltrials.gov demonstrates that this study was launched on August 1st 2022 and its most recent update occurred September 1st 2022."

Answered by AI

How many individuals are currently being enrolled in this research project?

"Affirmative. The clinicaltrials.gov database demonstrates that this medical research, which was originally posted on August 1st 2022, is presently recruiting participants. 10 patients need to be recruited from one site."

Answered by AI